NIH-funded research R01 grant

Dopamine signals in the frontal brain and persistent alcohol drinking

Official title: Mesocortical neuromodulation in punishment-resistant alcohol drinking

Funded at Vanderbilt University · NIH-11330292 · Data updated 2026-11-12

This work looks at how dopamine signals in a decision-making part of the brain may drive heavy, punishment-resistant drinking to help people with alcohol use disorder.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startJune 25, 2022
Project endMarch 31, 2027
Funding year2026
Award (this year)$393,097
NIH project number5R01AA030115-05
Project IDNIH-11330292 on NIH RePORTER

Who could benefit from this research

Could help

People with alcohol use disorder—especially those who continue drinking despite negative consequences—would be the eventual beneficiaries of work like this.

Less likely to help

Patients with mild or occasional drinking, those whose problems are driven mainly by other substances or medical issues, or anyone seeking an immediate treatment are unlikely to directly benefit from this preclinical work.

What this research studies

From a patient perspective, researchers are using a new glowing sensor to watch dopamine release in the medial prefrontal cortex while animals take alcohol, to learn how those brain signals relate to drinking. They will record responses to different stimuli and track how dopamine patterns change as drinking starts and becomes repetitive. The team will also turn the mesocortical system up or down to see whether changing these signals alters alcohol-seeking and drinking behaviors. Although the experiments use mice, the goal is to reveal brain mechanisms that could guide future treatments for people with alcohol problems.

Why it matters

Potential benefit: If successful, the findings could point to brain circuits or signals to target with new therapies that reduce compulsive alcohol use.

How similar studies have gone: Animal research has long linked dopamine to addiction, but using genetically encoded fluorescent dopamine sensors in the prefrontal cortex is a recent and relatively novel approach.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Siciliano, Cody — Vanderbilt University
  • Study coordinator: Siciliano, Cody

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.